Loading…
HCA Healthcare, Inc. is projected to rise to $424.62 by 2027, a +9% move from its current price of $389.62. HCA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $382.05 | $389.76 | $397.63 | +0.04% |
| Jul 30 | $379.04 | $389.91 | $401.08 | +0.07% |
| Jul 31 | $376.78 | $390.05 | $403.79 | +0.11% |
| Aug 1 | $374.90 | $390.19 | $406.10 | +0.15% |
| Aug 2 | $373.27 | $390.33 | $408.17 | +0.18% |
| Aug 3 | $371.82 | $390.48 | $410.07 | +0.22% |
| Aug 4 | $370.50 | $390.62 | $411.83 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $370.50 | $390.62 | $411.83 | +0.26% |
| Week 2 | $363.40 | $391.62 | $422.03 | +0.51% |
| Week 3 | $358.26 | $392.63 | $430.29 | +0.77% |
| Week 4 | $354.13 | $393.63 | $437.55 | +1.03% |
| Week 5 | $350.63 | $394.64 | $444.18 | +1.29% |
| Week 6 | $347.58 | $395.66 | $450.37 | +1.55% |
| Week 7 | $344.88 | $396.67 | $456.24 | +1.81% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.
Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. (HCA) is trading at $378.85 per share. It has a market capitalization of $84.04B and is ranked 194 by market cap.
The near-term technical backdrop is BEARISH, with RSI14 at 40, and the stock trading below key moving averages: SMA50 at $396.48 and SMA200 at $459.51.
Key levels include support at $361.32 and resistance at $423.11, with a 30-day price range of $329.66 to $435.38. Annualized volatility stands at 40%.
A major floor 14.6% below — a decisive break under it would weaken the trend.
The nearest floor, 6.7% below — buyers have tended to step in here.
The nearest ceiling, 8.6% above — a clean break opens room to run.
A major ceiling 30.9% above — clearing it would confirm fresh momentum.
Key HCA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $376.30 | Buy | $380.05 | Buy |
| MA 10 | $377.16 | Buy | $381.49 | Buy |
| MA 20 | $390.78 | Sell | $385.36 | Buy |
| MA 50 | $389.14 | Buy | $398.35 | Sell |
| MA 100 | $435.80 | Sell | $420.06 | Sell |
| MA 200 | $457.80 | Sell | $430.07 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.00 | Neutral |
| Stoch RSI (14) | 50.69 | Neutral |
| CCI (20) | -5.65 | Neutral |
| Williams %R (14) | -56.28 | Info |
| MACD (12,26,9) | -0.93 | Sell |
| ROC (12) | -5.11 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 43.72 | Neutral |
| TRIX (15) | -0.10 | Sell |
| Awesome (5,34) | -10.52 | Sell |
| Ultimate (7,14,28) | 53.96 | Neutral |
| Momentum (10) | -16.97 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 377.72 | Buy |
| ADX (14) | 16.96 | Neutral |
| ATR (14) | 7.63 | Info |
The 30-day technical picture shows BEARISH sentiment with RSI14 at 40.
The price action has the SMA50 at $396.48 and the SMA200 at $459.51, indicating a near-term downward bias relative to these moving averages.
Support is observed at $361.32 and resistance at $423.11, with the 30-day range between $329.66 and $435.38.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $361.32 | $389.62 | $509.06 | 0% | Neutral | |
| $346.80 | $424.62 | $544.25 | +9% | Neutral | |
| $373.49 | $466.56 | $615.31 | +20% | Neutral | |
| $390.46 | $495.85 | $668.72 | +27% | Bullish | |
| $436.89 | $562.85 | $773.57 | +44% | Bullish | |
| $496.83 | $648.46 | $906.11 | +66% | Bullish | |
| $528.32 | $697.93 | $989.88 | +79% | Bullish | |
| $557.87 | $745.29 | $1,071.47 | +91% | Bullish | |
| $559.21 | $755.07 | $1,099.19 | +94% | Bullish | |
| $575.73 | $785.27 | $1,156.54 | +102% | Bullish | |
| $804.12 | $1,147.59 | $1,775.28 | +195% | Bullish | |
| $1,498.57 | $2,306.46 | $3,836.75 | +492% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $361.32 | $389.62 | $457.59 | +0.00% |
| August 2026 | $344.75 | $402.62 | $479.69 | +3.34% |
| September 2026 | $342.92 | $402.84 | $484.58 | +0.05% |
| October 2026 | $339.87 | $401.18 | $486.29 | -0.41% |
| November 2026 | $346.07 | $410.11 | $500.24 | +2.23% |
| December 2026 | $348.91 | $414.97 | $509.06 | +1.18% |
Click any year to see its month-by-month HCA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, HCA could reach as high as $509.06, with a base case around $389.62 and support toward $361.32 — roughly 0% from $389.62. A consolidation phase looks the most probable path here.
Expect HCA to range from $346.80 to $544.25 through 2027. The $424.62 average target implies a +9% move from current prices. That is up +9% on the projected 2026 average. Price action looks broadly range-bound.
The HCA price prediction for 2028 points to an average of $466.56 (low $373.49, high $615.31) — a potential gain of +20% on today's $389.62. A consolidation phase looks the most probable path here.
In 2029, HCA is projected to trade between $390.46 and $668.72, averaging $495.85 — a potential gain of +27% from today's $389.62. That is up +6% on the projected 2028 average. Momentum favours further upside here.
HCA Healthcare, Inc.'s 2030 outlook centres on $562.85, within a $436.89 to $773.57 range. That is up +14% on the projected 2029 average. That marks a +44% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, HCA could reach as high as $906.11, with a base case around $648.46 and support toward $496.83 — roughly +66% from $389.62. Momentum favours further upside here.
Expect HCA to range from $528.32 to $989.88 through 2032. The $697.93 average target implies a +79% move from current prices. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The HCA price prediction for 2033 points to an average of $745.29 (low $557.87, high $1,071.47) — a potential gain of +91% on today's $389.62. Momentum favours further upside here.
In 2034, HCA is projected to trade between $559.21 and $1,099.19, averaging $755.07 — a potential gain of +94% from today's $389.62. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
HCA Healthcare, Inc.'s 2035 outlook centres on $785.27, within a $575.73 to $1,156.54 range. That is up +4% on the projected 2034 average. That marks a +102% change versus current levels. Momentum favours further upside here.
By 2040, HCA could reach as high as $1,775.28, with a base case around $1,147.59 and support toward $804.12 — roughly +195% from $389.62. Buyers look set to stay in control over this stretch.
Expect HCA to range from $1,498.57 to $3,836.75 through 2050. The $2,306.46 average target implies a +492% move from current prices. That is up +101% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HCA today (≈ 2.566603 HCA) could be worth
$5,919.78
+$4,919.78 (+492%) by 2050 · US Dollar
Based on the average projected HCA price of $2,306.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCAwould be worth at today's price.
$1,000 invested in HCA on Jul 28, 2025 (≈ 2.936513 HCA) would be worth
$1,144.12
+$144.12 (+14.4%) today · 1.14× · US Dollar
Based on a HCA entry price of $340.54 vs. today's $389.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $370.42 | $1,051.83 | +5.2% |
| 1 month ago | $391.68 | $994.74 | -0.5% |
| 3 months ago | $431.92 | $902.07 | -9.8% |
| 6 months ago | $491.23 | $793.15 | -20.7% |
| 1 year ago | $340.54 | $1,144.12 | +14.4% |
| All time (5.0y) ago | $247.9 | $1,571.68 | +57.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCA forecast.
Our base-case forecast reaches $780.00 around 2035.
Implied market cap at $780.00: $173.04B
The multi-year forecast outlines a bullish trajectory, with sentiment turning BULLISH in later years and rising price targets across the horizon.
2026 projects a min of $361.32, an avg of $378.85, and a max of $493.90, with ROI of 0 and a NEUTRAL sentiment.
2030 shows a min of $410.94, an avg of $533.26, and a max of $739.72, with ROI of 40.8 and a BULLISH sentiment.
2040 reflects a min of $746.57, an avg of $1,080.29, and a max of $1,694.94, with ROI of 185.2 and a BULLISH sentiment.
2050 foresees a min of $1,347.91, an avg of $2,114.99, and a max of $3,578.27, with ROI of 458.3 and a BULLISH sentiment. These are estimates and not guarantees; the figures imply substantial long-term upside but carry inherent investment risk and uncertainty.
Tap a question to reveal the answer.
The 2030 forecast lists min $410.94, avg $533.26, max $739.72; ROI 40.8%; sentiment BULLISH. These are estimates, not guarantees.
Forecasts show rising price levels with ROI reaching 40.8% by 2030, 64.3% by 2031, 73.7% by 2032, 85.5% by 2033, and up to 458.3% by 2050; current technical sentiment is BEARISH but long-term outlook is BULLISH.
Yes. The 2035 forecast lists min $529.90, avg $730.60, max $1,089.16; ROI 92.8%; sentiment BULLISH. These are estimates, not guarantees.
Current price is $378.85. For 2040: min $746.57, avg $1,080.29, max $1,694.94; ROI 185.2%; sentiment BULLISH.
2050 forecast: min $1,347.91, avg $2,114.99, max $3,578.27; ROI 458.3%; sentiment BULLISH.
HCA Healthcare, Inc. Community Discussion
0Share your HCA Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.